Innovation

Iminosugar Compounds with Antiflavirus activity

Institute for Hepatitis and Virus Research
posted on 02/15/2009

Novel flavivirus replication inhibitors, bis-amide pyrolidine derivatives, and pharmaceutical compositions and the use thereof to treat disorders caused by West Nile virus, Bovine Viral Diarrhea virus, Hepatitis B virus and other emerging flaviviruses, such as, for example, JEV, SLEV, AV, KV, JV, CV, YV, TBEV, dengue viruses (e.g., DENV-1, DENV-2, DENV-3, DENV-4), YFV and MVEV.


Innovation Details
 

File Number: 07-1B 

Disease: Infectious Diseases


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Ethan Byler at Institute for Hepatitis and Virus Research for more information.

Request more info via email request more info
People

Case Manager:

Ethan Byler Ethan Byler

Innovations (11)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...